Medical Abortion Self-Confirmation (MASC)

Stanford University88 enrolled

Overview

This study aims to investigate the ability of participants to perform and accurately interpret the multi-level pregnancy test and the low sensitivity pregnancy test following medication abortion, without routine provider contact.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Medical Abortion

Interventions

Self-assessment: MLPTBEHAVIORAL

Patients enrolled in the study will self-assess the outcomes of their medical abortion using the multi-level pregnancy test.

Self-assessment: LSPTBEHAVIORAL

Patients enrolled in the study will self-assess the outcomes of their medical abortion using the low sensitivity pregnancy test.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Gestational age of less than or equal to 63 days * English speaking * Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria * In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form Exclusion Criteria: * Allergy to mifepristone and/or misoprostol * Non-english speaking * Inability to access internet

Locations (1)

Stanford Health Care

Stanford, California, United States

Outcomes

Primary Outcomes

Correct interpretation of pregnancy test

Time frame: 4 weeks after taking medication abortion medication, mifepristone

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.